313 related articles for article (PubMed ID: 34367952)
1. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S
Front Oncol; 2021; 11():651622. PubMed ID: 34367952
[TBL] [Abstract][Full Text] [Related]
2. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
3. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
4. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
5. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
[TBL] [Abstract][Full Text] [Related]
6. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
Lai J; Lin X; Zheng H; Xie B; Fu D
BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
[TBL] [Abstract][Full Text] [Related]
7. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
8. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
9. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers for acute leukemia via machine learning-based stemness index.
Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H
Gene; 2021 Dec; 804():145903. PubMed ID: 34411647
[TBL] [Abstract][Full Text] [Related]
11. The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis.
Zhang T; Yan C; Ye Z; Yin X; Jiang TA
Comb Chem High Throughput Screen; 2021; 24(3):423-432. PubMed ID: 32767928
[TBL] [Abstract][Full Text] [Related]
12. Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA.
Zhang B; He Y; Ma G; Zhang L; Qi P; Han D; Yue Z; Shang P
Mol Cell Probes; 2022 Dec; 66():101867. PubMed ID: 36183925
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Pei J; Wang Y; Li Y
J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
[TBL] [Abstract][Full Text] [Related]
14. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Xu H; Zou R; Liu J; Zhu L
J Oncol; 2021; 2021():6653247. PubMed ID: 33747079
[TBL] [Abstract][Full Text] [Related]
15. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Guo F; Hong J
Front Genet; 2020; 11():441. PubMed ID: 32431729
[TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
Zhao X; Lin J
Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
[TBL] [Abstract][Full Text] [Related]
18. Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
Zhang G
Discov Oncol; 2023 Nov; 14(1):203. PubMed ID: 37957420
[TBL] [Abstract][Full Text] [Related]
19. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
Wang Y; Wan X; Du S
Front Immunol; 2023; 14():1100100. PubMed ID: 37622118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
